25 XP   0   0   10

Qianjiang Yongan Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Qianjiang Yongan Pharmaceutical Co Ltd together

PenkeI guess you are interested in Qianjiang Yongan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Qianjiang Yongan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Qianjiang Yongan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Qianjiang Yongan Pharmaceutical Co Ltd.

Quick analysis of Qianjiang Yongan Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Qianjiang Yongan Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.14
Expected worth in 1 year
¥9.12
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.00
Return On Investment
31.4%

For what price can you sell your share?

Current Price per Share
¥6.38
Expected price per share
¥5.45 - ¥7.09
How sure are you?
50%

1. Valuation of Qianjiang Yongan Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.38

Intrinsic Value Per Share

¥4.73 - ¥13.71

Total Value Per Share

¥11.87 - ¥20.85

2. Growth of Qianjiang Yongan Pharmaceutical Co Ltd (5 min.)




Is Qianjiang Yongan Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$290.6m$270.4m$20.1m6.9%

How much money is Qianjiang Yongan Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$19.3m$15.3m$3.9m20.6%
Net Profit Margin9.6%7.1%--

How much money comes from the company's main activities?

3. Financial Health of Qianjiang Yongan Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Qianjiang Yongan Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Qianjiang Yongan Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Qianjiang Yongan Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Qianjiang Yongan Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Qianjiang Yongan Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Qianjiang Yongan Pharmaceutical Co Ltd is ¥6.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Qianjiang Yongan Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Qianjiang Yongan Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.14. Based on the TTM, the Book Value Change Per Share is ¥0.50 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Qianjiang Yongan Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.071.0%0.071.0%0.050.8%0.060.9%0.040.7%
Usd Book Value Change Per Share0.071.1%0.071.1%0.071.1%0.071.1%0.050.7%
Usd Dividend Per Share0.000.0%0.000.0%0.010.2%0.010.2%0.010.2%
Usd Total Gains Per Share0.071.1%0.071.1%0.081.3%0.081.3%0.060.9%
Usd Price Per Share1.45-1.45-1.47-1.40-2.09-
Price to Earnings Ratio22.05-22.05-29.01-25.39-90.70-
Price-to-Total Gains Ratio20.96-20.96-17.98-19.92-75.87-
Price to Book Ratio1.47-1.47-1.60-1.65-3.31-
Price-to-Total Gains Ratio20.96-20.96-17.98-19.92-75.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.881716
Number of shares1134
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.070.07
Usd Total Gains Per Share0.070.08
Gains per Quarter (1134 shares)78.4994.19
Gains per Year (1134 shares)313.97376.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1331130454323367
27621618108645744
3109329321629681121
4131243124621612911498
5171553156027116131875
6201864187432519362252
7232174218837922582629
8272485250243325813006
9302796281648729043383
10333106313054132263760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%13.01.00.092.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.00.0100.0%

Fundamentals of Qianjiang Yongan Pharmaceutical Co Ltd

About Qianjiang Yongan Pharmaceutical Co Ltd

Qianjiang Yongan Pharmaceutical Co., Ltd. manufactures and sells taurine in China. It produces ethylene oxide, water reducers, and health products. The company engages in scientific research and technical service, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.

Fundamental data was last updated by Penke on 2024-04-14 15:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Qianjiang Yongan Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Qianjiang Yongan Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.6% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 9.6%. The company is making a profit. +1
  • The TTM is 9.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.6%TTM9.6%0.0%
TTM9.6%YOY7.1%+2.5%
TTM9.6%5Y10.0%-0.4%
5Y10.0%10Y8.8%+1.2%
1.1.2. Return on Assets

Shows how efficient Qianjiang Yongan Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.8% Return on Assets means that Qianjiang Yongan Pharmaceutical Co Ltd generated ¥0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 5.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY4.9%+0.9%
TTM5.8%5Y5.9%-0.1%
5Y5.9%10Y4.9%+1.0%
1.1.3. Return on Equity

Shows how efficient Qianjiang Yongan Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.0% Return on Equity means Qianjiang Yongan Pharmaceutical Co Ltd generated ¥0.07 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 7.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.0%TTM7.0%0.0%
TTM7.0%YOY6.0%+1.0%
TTM7.0%5Y7.2%-0.2%
5Y7.2%10Y5.8%+1.4%

1.2. Operating Efficiency of Qianjiang Yongan Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Qianjiang Yongan Pharmaceutical Co Ltd is operating .

  • Measures how much profit Qianjiang Yongan Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY8.0%-8.0%
TTM-5Y9.2%-9.2%
5Y9.2%10Y8.5%+0.7%
1.2.2. Operating Ratio

Measures how efficient Qianjiang Yongan Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are ¥1.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 1.560. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.560. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.560TTM1.5600.000
TTM1.560YOY1.688-0.128
TTM1.5605Y1.595-0.034
5Y1.59510Y1.333+0.262

1.3. Liquidity of Qianjiang Yongan Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Qianjiang Yongan Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.19 means the company has ¥4.19 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 4.192. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.192. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.192TTM4.1920.000
TTM4.192YOY3.633+0.559
TTM4.1925Y3.514+0.678
5Y3.51410Y2.913+0.601
1.3.2. Quick Ratio

Measures if Qianjiang Yongan Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.56 means the company can pay off ¥2.56 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 2.562. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.562. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.562TTM2.5620.000
TTM2.562YOY2.720-0.158
TTM2.5625Y2.172+0.390
5Y2.17210Y2.759-0.587

1.4. Solvency of Qianjiang Yongan Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Qianjiang Yongan Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Qianjiang Yongan Pharmaceutical Co Ltd assets are financed with 13.2% credit (debt) and the remaining percentage (100% - 13.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 0.132. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.132. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.1320.000
TTM0.132YOY0.144-0.011
TTM0.1325Y0.147-0.015
5Y0.14710Y0.120+0.027
1.4.2. Debt to Equity Ratio

Measures if Qianjiang Yongan Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 15.9% means that company has ¥0.16 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The MRQ is 0.159. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.159. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.159TTM0.1590.000
TTM0.159YOY0.176-0.017
TTM0.1595Y0.179-0.020
5Y0.17910Y0.141+0.038

2. Market Valuation of Qianjiang Yongan Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Qianjiang Yongan Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Qianjiang Yongan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 22.05 means the investor is paying ¥22.05 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The EOD is 13.396. Based on the earnings, the company is underpriced. +1
  • The MRQ is 22.046. Based on the earnings, the company is fair priced.
  • The TTM is 22.046. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.396MRQ22.046-8.651
MRQ22.046TTM22.0460.000
TTM22.046YOY29.008-6.962
TTM22.0465Y25.394-3.348
5Y25.39410Y90.696-65.302
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The EOD is 7.893. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.989. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.989. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.893MRQ12.989-5.097
MRQ12.989TTM12.9890.000
TTM12.989YOY80.660-67.670
TTM12.9895Y43.481-30.492
5Y43.48110Y26.673+16.808
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Qianjiang Yongan Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Qianjiang Yongan Pharmaceutical Co Ltd:

  • The EOD is 0.894. Based on the equity, the company is cheap. +2
  • The MRQ is 1.471. Based on the equity, the company is underpriced. +1
  • The TTM is 1.471. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.894MRQ1.471-0.577
MRQ1.471TTM1.4710.000
TTM1.471YOY1.598-0.126
TTM1.4715Y1.652-0.181
5Y1.65210Y3.312-1.660
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Qianjiang Yongan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4960.4960%0.486+2%0.515-4%0.342+45%
Book Value Per Share--7.1377.1370%6.641+7%6.201+15%5.079+41%
Current Ratio--4.1924.1920%3.633+15%3.514+19%2.913+44%
Debt To Asset Ratio--0.1320.1320%0.144-8%0.147-10%0.120+10%
Debt To Equity Ratio--0.1590.1590%0.176-10%0.179-11%0.141+13%
Dividend Per Share--0.0050.0050%0.104-95%0.086-94%0.070-92%
Eps--0.4760.4760%0.366+30%0.421+13%0.302+58%
Free Cash Flow Per Share--0.8080.8080%0.132+515%0.359+125%0.153+429%
Free Cash Flow To Equity Per Share--0.8690.8690%-0.341+139%0.282+209%0.149+483%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--13.713--------
Intrinsic Value_10Y_min--4.732--------
Intrinsic Value_1Y_max--0.634--------
Intrinsic Value_1Y_min--0.236--------
Intrinsic Value_3Y_max--2.469--------
Intrinsic Value_3Y_min--0.920--------
Intrinsic Value_5Y_max--4.984--------
Intrinsic Value_5Y_min--1.829--------
Market Cap1880071057.920-65%3094166250.0003094166250.0000%3126581325.000-1%2993384835.000+3%4465909795.728-31%
Net Profit Margin--0.0960.0960%0.071+35%0.100-4%0.088+9%
Operating Margin----0%0.080-100%0.092-100%0.085-100%
Operating Ratio--1.5601.5600%1.688-8%1.595-2%1.333+17%
Pb Ratio0.894-65%1.4711.4710%1.598-8%1.652-11%3.312-56%
Pe Ratio13.396-65%22.04622.0460%29.008-24%25.394-13%90.696-76%
Price Per Share6.380-65%10.50010.5000%10.610-1%10.158+3%15.155-31%
Price To Free Cash Flow Ratio7.893-65%12.98912.9890%80.660-84%43.481-70%26.673-51%
Price To Total Gains Ratio12.738-65%20.96420.9640%17.978+17%19.922+5%75.870-72%
Quick Ratio--2.5622.5620%2.720-6%2.172+18%2.759-7%
Return On Assets--0.0580.0580%0.049+19%0.059-2%0.049+18%
Return On Equity--0.0700.0700%0.060+17%0.072-3%0.058+21%
Total Gains Per Share--0.5010.5010%0.590-15%0.601-17%0.413+21%
Usd Book Value--290635445.425290635445.4250%270454483.659+7%252531237.546+15%206822616.692+41%
Usd Book Value Change Per Share--0.0680.0680%0.067+2%0.071-4%0.047+45%
Usd Book Value Per Share--0.9860.9860%0.918+7%0.857+15%0.702+41%
Usd Dividend Per Share--0.0010.0010%0.014-95%0.012-94%0.010-92%
Usd Eps--0.0660.0660%0.051+30%0.058+13%0.042+58%
Usd Free Cash Flow--32920224.59632920224.5960%5356993.936+515%14618901.340+125%6218180.518+429%
Usd Free Cash Flow Per Share--0.1120.1120%0.018+515%0.050+125%0.021+429%
Usd Free Cash Flow To Equity Per Share--0.1200.1200%-0.047+139%0.039+209%0.021+483%
Usd Market Cap259825820.205-65%427613775.750427613775.7500%432093539.115-1%413685784.197+3%617188733.770-31%
Usd Price Per Share0.882-65%1.4511.4510%1.466-1%1.404+3%2.094-31%
Usd Profit--19396248.57919396248.5790%15397696.217+26%17298256.070+12%12349982.806+57%
Usd Revenue--202110251.178202110251.1780%216339548.899-7%181776149.745+11%135196231.124+49%
Usd Total Gains Per Share--0.0690.0690%0.082-15%0.083-17%0.057+21%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+24 -1110Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Qianjiang Yongan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.396
Price to Book Ratio (EOD)Between0-10.894
Net Profit Margin (MRQ)Greater than00.096
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.562
Current Ratio (MRQ)Greater than14.192
Debt to Asset Ratio (MRQ)Less than10.132
Debt to Equity Ratio (MRQ)Less than10.159
Return on Equity (MRQ)Greater than0.150.070
Return on Assets (MRQ)Greater than0.050.058
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Qianjiang Yongan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.674
Ma 20Greater thanMa 507.388
Ma 50Greater thanMa 1007.179
Ma 100Greater thanMa 2008.512
OpenGreater thanClose6.910
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,424,179
Total Liabilities321,173
Total Stockholder Equity2,017,377
 As reported
Total Liabilities 321,173
Total Stockholder Equity+ 2,017,377
Total Assets = 2,424,179

Assets

Total Assets2,424,179
Total Current Assets1,195,344
Long-term Assets1,228,835
Total Current Assets
Cash And Cash Equivalents 274,716
Short-term Investments 557,503
Net Receivables 172,942
Inventory 149,598
Other Current Assets 18,179
Total Current Assets  (as reported)1,195,344
Total Current Assets  (calculated)1,172,939
+/- 22,406
Long-term Assets
Property Plant Equipment 1,023,451
Goodwill 8,766
Intangible Assets 84,493
Long-term Assets Other 21,020
Long-term Assets  (as reported)1,228,835
Long-term Assets  (calculated)1,137,730
+/- 91,105

Liabilities & Shareholders' Equity

Total Current Liabilities285,127
Long-term Liabilities36,046
Total Stockholder Equity2,017,377
Total Current Liabilities
Short Long Term Debt 40,014
Accounts payable 162,771
Other Current Liabilities 8,199
Total Current Liabilities  (as reported)285,127
Total Current Liabilities  (calculated)210,984
+/- 74,143
Long-term Liabilities
Other Liabilities 36,046
Long-term Liabilities  (as reported)36,046
Long-term Liabilities  (calculated)36,046
+/- 0
Total Stockholder Equity
Common Stock294,683
Retained Earnings 995,202
Other Stockholders Equity 14,714
Total Stockholder Equity (as reported)2,017,377
Total Stockholder Equity (calculated)1,304,599
+/- 712,778
Other
Capital Stock294,683
Common Stock Shares Outstanding 294,683
Net Invested Capital 2,057,391
Net Tangible Assets 1,924,117
Net Working Capital 910,217
Property Plant and Equipment Gross 1,023,451



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
393,999
1,090,712
1,160,418
1,210,780
1,202,353
1,187,029
1,202,988
1,273,318
1,579,918
1,929,049
1,907,849
2,163,733
2,285,926
2,424,179
2,424,1792,285,9262,163,7331,907,8491,929,0491,579,9181,273,3181,202,9881,187,0291,202,3531,210,7801,160,4181,090,712393,999
   > Total Current Assets 
0
0
0
0
0
0
0
630,701
722,730
766,931
757,039
1,027,548
1,065,891
1,195,344
1,195,3441,065,8911,027,548757,039766,931722,730630,7010000000
       Cash And Cash Equivalents 
76,743
517,589
227,259
220,823
124,129
30,625
59,397
89,010
132,360
22,962
117,335
114,196
93,506
274,716
274,71693,506114,196117,33522,962132,36089,01059,39730,625124,129220,823227,259517,58976,743
       Short-term Investments 
0
0
0
0
0
279,000
293,000
16,331
17,332
34,702
384,706
634,101
454,023
557,503
557,503454,023634,101384,70634,70217,33216,331293,000279,00000000
       Net Receivables 
48,909
55,945
75,261
81,467
65,860
84,813
92,185
83,283
159,234
144,004
129,995
126,103
343,900
172,942
172,942343,900126,103129,995144,004159,23483,28392,18584,81365,86081,46775,26155,94548,909
       Inventory 
9,329
19,369
18,039
19,873
25,966
43,737
52,873
61,202
80,500
97,356
104,129
81,668
145,777
149,598
149,598145,77781,668104,12997,35680,50061,20252,87343,73725,96619,87318,03919,3699,329
   > Long-term Assets 
0
0
0
0
0
0
0
642,618
857,188
1,162,118
1,150,809
1,136,185
1,220,035
1,228,835
1,228,8351,220,0351,136,1851,150,8091,162,118857,188642,6180000000
       Property Plant Equipment 
221,838
259,493
468,669
638,632
691,742
634,106
596,221
556,013
664,527
1,015,539
1,010,229
990,470
989,262
1,023,451
1,023,451989,262990,4701,010,2291,015,539664,527556,013596,221634,106691,742638,632468,669259,493221,838
       Goodwill 
0
0
0
0
0
0
0
0
0
8,766
8,766
8,766
8,766
8,766
8,7668,7668,7668,7668,766000000000
       Intangible Assets 
364
362
542
492
11,239
79,150
82,730
78,896
92,560
88,640
88,247
89,821
87,934
84,493
84,49387,93489,82188,24788,64092,56078,89682,73079,15011,239492542362364
       Long-term Assets Other 
0
0
0
0
0
0
0
1,517
91,455
40,110
4,504
2,485
8,601
21,020
21,0208,6012,4854,50440,11091,4551,5170000000
> Total Liabilities 
69,828
76,141
104,128
116,586
122,503
79,143
83,496
96,217
235,231
323,115
251,135
349,925
328,947
321,173
321,173328,947349,925251,135323,115235,23196,21783,49679,143122,503116,586104,12876,14169,828
   > Total Current Liabilities 
30,551
35,427
66,175
79,754
89,100
49,545
58,965
77,071
213,846
274,755
207,901
310,239
293,367
285,127
285,127293,367310,239207,901274,755213,84677,07158,96549,54589,10079,75466,17535,42730,551
       Short-term Debt 
0
0
0
0
0
0
0
10,059
0
2,000
0
0
0
0
00002,000010,0590000000
       Short Long Term Debt 
0
0
0
0
0
0
0
10,059
0
2,000
3,000
122,347
20,380
40,014
40,01420,380122,3473,0002,000010,0590000000
       Accounts payable 
20,715
15,277
47,121
58,114
69,213
32,210
43,573
38,599
47,943
142,364
111,152
97,580
114,907
162,771
162,771114,90797,580111,152142,36447,94338,59943,57332,21069,21358,11447,12115,27720,715
       Other Current Liabilities 
9,836
20,150
19,054
21,640
19,887
17,335
15,391
8,315
141,659
88,762
56,457
49,646
111,081
8,199
8,199111,08149,64656,45788,762141,6598,31515,39117,33519,88721,64019,05420,1509,836
   > Long-term Liabilities 
0
0
0
0
0
0
0
19,146
21,385
48,359
43,234
39,686
35,580
36,046
36,04635,58039,68643,23448,35921,38519,1460000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
18,794
0
0
0
0
0
0
00000018,7940000000
> Total Stockholder Equity
324,171
1,014,571
1,056,289
1,094,194
1,079,850
1,107,887
1,115,422
1,173,339
1,341,121
1,579,896
1,612,901
1,755,713
1,865,919
2,017,377
2,017,3771,865,9191,755,7131,612,9011,579,8961,341,1211,173,3391,115,4221,107,8871,079,8501,094,1941,056,2891,014,571324,171
   Common Stock
70,000
93,500
187,000
187,000
187,000
187,000
187,000
187,000
196,455
294,683
294,683
294,683
294,683
294,683
294,683294,683294,683294,683294,683196,455187,000187,000187,000187,000187,000187,00093,50070,000
   Retained Earnings 
196,240
190,986
225,731
255,894
238,107
314,398
320,790
377,478
490,983
649,922
710,386
772,865
854,853
995,202
995,202854,853772,865710,386649,922490,983377,478320,790314,398238,107255,894225,731190,986196,240
   Capital Surplus 00000000000000
   Treasury Stock00000-126,88600000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
4,295
2,565
1,107
1,245
838
4,155
14,714
14,7144,1558381,2451,1072,5654,2950000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,142,144
Cost of Revenue-749,576
Gross Profit392,568392,568
 
Operating Income (+$)
Gross Profit392,568
Operating Expense-1,084,522
Operating Income57,623-691,953
 
Operating Expense (+$)
Research Development43,506
Selling General Administrative231,362
Selling And Marketing Expenses-
Operating Expense1,084,522274,867
 
Net Interest Income (+$)
Interest Income307
Interest Expense-331
Other Finance Cost-17,487
Net Interest Income-17,511
 
Pretax Income (+$)
Operating Income57,623
Net Interest Income-17,511
Other Non-Operating Income Expenses-
Income Before Tax (EBT)46,30157,623
EBIT - interestExpense = -331
25,125
25,456
Interest Expense331
Earnings Before Interest and Taxes (EBIT)-46,631
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax46,301
Tax Provision-27,282
Net Income From Continuing Ops19,01919,019
Net Income25,125
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-17,511
 

Technical Analysis of Qianjiang Yongan Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Qianjiang Yongan Pharmaceutical Co Ltd. The general trend of Qianjiang Yongan Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Qianjiang Yongan Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Qianjiang Yongan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.71 < 6.78 < 7.09.

The bearish price targets are: 5.45.

Tweet this
Qianjiang Yongan Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Qianjiang Yongan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Qianjiang Yongan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Qianjiang Yongan Pharmaceutical Co Ltd. The current macd is -0.08206766.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Qianjiang Yongan Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Qianjiang Yongan Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Qianjiang Yongan Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Qianjiang Yongan Pharmaceutical Co Ltd. The current adx is 17.65.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Qianjiang Yongan Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Qianjiang Yongan Pharmaceutical Co Ltd. The current sar is 7.7232.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Qianjiang Yongan Pharmaceutical Co Ltd. The current rsi is 29.67. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Qianjiang Yongan Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Qianjiang Yongan Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Qianjiang Yongan Pharmaceutical Co Ltd. The current cci is -339.38547486.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Qianjiang Yongan Pharmaceutical Co Ltd. The current cmo is -55.60103155.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Qianjiang Yongan Pharmaceutical Co Ltd. The current willr is -98.55072464.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Williams %R ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Qianjiang Yongan Pharmaceutical Co Ltd.

Qianjiang Yongan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Qianjiang Yongan Pharmaceutical Co Ltd. The current atr is 0.30618309.

Qianjiang Yongan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Qianjiang Yongan Pharmaceutical Co Ltd. The current obv is -29,504,637.

Qianjiang Yongan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Qianjiang Yongan Pharmaceutical Co Ltd. The current mfi is 57.00.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Qianjiang Yongan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartQianjiang Yongan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Qianjiang Yongan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Qianjiang Yongan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Qianjiang Yongan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.674
Ma 20Greater thanMa 507.388
Ma 50Greater thanMa 1007.179
Ma 100Greater thanMa 2008.512
OpenGreater thanClose6.910
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Qianjiang Yongan Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Qianjiang Yongan Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Qianjiang Yongan Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Qianjiang Yongan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Qianjiang Yongan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Qianjiang Yongan Pharmaceutical Co Ltd.

Receive notifications about Qianjiang Yongan Pharmaceutical Co Ltd in your mailbox!